Nuzenio

Psoriatic Disease

Psoriatic Disease news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 11 publisher sources 100/100 entity strength

Latest news

MoonLake’s Psoriatic Arthritis Drug Shows Promise In Phase 3 Trial – Retail Shrugs Off Premarket Slide, Says ‘Pipeline Is Intact’ - StocktwitsStocktwits · Mon, 10 Aug 2026 13:27:16 GMT L-17 vs IL-23: Head-to-Head Data in Psoriasis and PsA - HCPLiveHCPLive · Mon, 10 Aug 2026 12:12:08 GMT Setting the Stage: The Burden of Psoriatic Arthritis and the Treatment Landscape - Managed Healthcare ExecutiveManaged Healthcare Executive · Mon, 10 Aug 2026 12:07:51 GMT Targeting the Pathways: TNF, IL-17, and IL-23 in Psoriasis - HCPLiveHCPLive · Mon, 10 Aug 2026 12:07:08 GMT Can Apremilast Curb PsA in Patients With Psoriasis? - MedscapeMedscape · Mon, 10 Aug 2026 11:29:50 GMT MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:23 GMT Drug-Induced Autoimmune Inflammatory Myositis in a Patient with Psoriatic Arthritis Receiving Biologic Therapy: A Case Report - EMJEMJ · Fri, 07 Aug 2026 15:22:52 GMT Perspectives on Psoriatic Arthritis - Everyday HealthEveryday Health · Thu, 06 Aug 2026 22:36:57 GMT

Timeline

Mon, 10 Aug 2026 13:27:16 GMTMoonLake’s Psoriatic Arthritis Drug Shows Promise In Phase 3 Trial – Retail Shrugs Off Premarket Slide, Says ‘Pipeline Is Intact’ - Stocktwits

Mon, 10 Aug 2026 12:12:08 GMTL-17 vs IL-23: Head-to-Head Data in Psoriasis and PsA - HCPLive

Mon, 10 Aug 2026 12:07:51 GMTSetting the Stage: The Burden of Psoriatic Arthritis and the Treatment Landscape - Managed Healthcare Executive

Mon, 10 Aug 2026 12:07:08 GMTTargeting the Pathways: TNF, IL-17, and IL-23 in Psoriasis - HCPLive

Mon, 10 Aug 2026 11:29:50 GMTCan Apremilast Curb PsA in Patients With Psoriasis? - Medscape

Mon, 10 Aug 2026 11:19:23 GMTMoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results - The Manila Times

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Psoriasis5 live mentions Psoriatic Arthritis5 live mentions Phase4 live mentions Trial4 live mentions PsA3 live mentions Hospital Healthcare Europe3 live mentions Psoriatic Arthritis Drug2 live mentions Shows Promise In2 live mentions Retail Shrugs Off2 live mentions Premarket Slide2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Psoriatic Disease.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.